发明名称 VERWENDUNG VON ALPHA-D-GALACTOSIDASE ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG ZUR LINDERUNG VON GASTRO-INTESTINALEN BESCHWERDEN DURCH ALPHA-D-GALACTOSID GEBUNDENE ZUCKER.
摘要 A composition is provided for ingestion by mammals for in vivo conversion of alpha-D-galactoside comprising an amount of alpha-galactosidase effective to hydrolyze alpha-D-galactoside to D-galactose, and non-toxic, ingestible excipients(s) for said alpha-galactrosidase. Gastric distress in mammals due to ingestion of foods containing alpha-D-galactoside may be reduced by ingesting the foregoing composition of alpha-galactosidase and non-toxic, ingestible excipient contemporaneously with the ingestion of said food in an amount effective to hydrolyze the alpha-D-galactoside to D-galactose.
申请公布号 DE69025933(T3) 申请公布日期 2002.09.05
申请号 DE1990625933T 申请日期 1990.05.10
申请人 BLOCK DRUG CO., INC. 发明人 KLIGERMAN, ALAN
分类号 A23L1/30;A23L1/03;A23L1/305;A61K38/46;A61K38/47;A61P1/14;C12N9/40 主分类号 A23L1/30
代理机构 代理人
主权项
地址